Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Anne McGeorge files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marino Garcia - $27.96M of DNTH open-market activity in the last 12 months
- M33 Growth I L.P. - $20.70M of STLN open-market activity in the last 12 months
- Ryan Savitz - $14.99M of DNTH open-market activity in the last 12 months
- Simrat Randhawa - $12.54M of DNTH open-market activity in the last 12 months
- Adam M. Veness - $4.63M of DNTH open-market activity in the last 12 months
- Edward Carr - $3.56M of DNTH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Anne McGeorge?
Anne McGeorge is a corporate insider, tracked as Director of Dianthus Therapeutics, Inc. /DE/ (DNTH). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anne McGeorge submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Anne McGeorge been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($845K) across all tracked filings.
Where can I see all of Anne McGeorge's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Anne McGeorge and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
